Clinical Trial Update: Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

View source ↗

Summary

A completed clinical trial update examining predictive biomarkers for response and toxicity in patients with hematologic malignancies treated with immunotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Blood Cancer | Status: COMPLETED